AQST - Aquestive Therapeutics GAAP EPS of -$0.32 beats by $0.09 revenue of $12.27M beats by $2.15M
Aquestive Therapeutics press release (NASDAQ:AQST): Q1 GAAP EPS of -$0.32 beats by $0.09. Revenue of $12.27M (+10.3% Y/Y) beats by $2.15M. Cash and cash equivalents of $14.7M as of March 31, 2022 vs $28M as of Dec. 31, 2021. Reconfirming FY 2022 financial outlook. Company expects total revenues of approximately $42 to $47 million.
For further details see:
Aquestive Therapeutics GAAP EPS of -$0.32 beats by $0.09, revenue of $12.27M beats by $2.15M